Medical Center, The James To Receive National Award

June 22, 2011

COLUMBUS, Ohio – The Department of Pharmacy at The Ohio State University Medical Center and the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) will be recognized for their outstanding Medication Assistance Program by receiving the American Pharmacists Association Foundation's Pinnacle Award during a presentation June 27 in Washington D.C.

The "Group Practice–Health System–Corporation Award" recognizes significant contributions to the medication use process through increasing patient adherence, reducing drug errors, promoting the use of national treatment guidelines, improving patient outcomes and enhancing communication among members of health care teams.

The Medication Assistance Program (MAP) helps patients obtain necessary medications through pharmaceutical manufacturer patient assistance programs, disease-based assistance grants, charity care dollars and other funding sources. The program allows healthcare professionals, social workers and financial counselors to assist patients at Ohio State's Medical Center hospitals, emergency departments, and outpatient clinics who have limited ability to pay for necessary medications.

"We are honored to receive this national recognition. This award demonstrates our teams' commitment to helping patients who may otherwise not receive the medication they need," said Niesha Griffith, director of Pharmacy and Infusion Services for OSUCCC – James and the MAP. "Our leadership at the James and OSUMC recognizes the value of this program to the organization and its patients, as we work to promote wellness."

The Ohio State Medical Center and OSUCCC – James MAP began in 2001 with the goal of assisting self-pay patients at the OSUCCC – James. The program has since grown, assisting more than 8,700 patients and obtaining more than $53 million worth of medications for either take-home or replacement purposes.

The program staff, familiar with the nuances of potential medication sources, provides patients with resources that are frequently not utilized due to the complexity involved with the application process and a general lack of awareness that assistance programs exist.

Continued communication between the patients, medication assistance coordinators, and pharmacists at the Ohio State Medical Center and OSUCCC – James MAP facilitates the transition of care between inpatient and outpatient settings, and also provides a high risk patient population an easily accessible point of contact.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 205-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven programs in the country funded by the NCI to conduct both Phase I and Phase II clinical trials.

# # #

Contact: Gina Bericchia, Medical Center Public Affairs and Media Relations, 614-293-3737, or Gina.Bericchia@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Curbing Cost: Study Suggests That Dopamine is a Safe Antiangiogenic Drug

A new study led by scientists at the OSUCCC – James suggests that the inexpensive drug dopamine can be safely used in cancer treatment to curb the growth of tumor blood vessels.

Read More

New Genomics Tool Could Help Predict Tumor Aggressiveness, Treatment Outcomes

A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study led by...

Read More

Advances in Melanoma Treatment and Research

In this week’s Toward a Cancer-Free World, OSUCCC – James skin cancer expert Dr. Kari Kendra tells us why today’s advances in melanoma research and treatment offer even greater hope to skin cancer...

Read More